The obtained results can therefore help to explain the results of our in vivo studies, where silencing of CD105 or CD146 was combined with IR, which potentiated the antitumor effectiveness resulting in the better therapeutic outcome on melanoma and carcinoma tumor models [15,51]. Here, MCAM is linked to carcinoma.